Mexico and Germany have agreed to create a high-level binational commission that will meet on a regular basis to strengthen bilateral relations, Germany’s foreign minister, Frank-Walter Steinmeier, said on Friday.
“We have agreed to form a consultation forum that is going to meet on a regular basis and will act at high-level”, he said.
The German minister, who is on an official visit to Mexico, and his Mexican counterpart, Jose Antonio Meade, agreed in a joint press conference that conditions are ripe to strengthen the trade relationship.
Steinmeier highlighted that it was in the interest of both countries to enhance export opportunities.
“Mexico and Germany are interested in a free, dynamic and open market, free and open international trade, and it is important to strengthen conditions to achieve it”, he added.
Describing Mexico as “a country that builds bridges between the north and the south of America” on many core issues, from the protection of the environment to cyber security, Steinmeier said German businessmen had confidence in the country’s development.
He cited the millions of dollars that carmaker BMW agreed to invest in the country and pointed out that a plant of the German cosmetics firm Beiersdorf will be inaugurated in Silao, in the central state of Guanajuato, on Saturday.
Meade, in turn, said the values shared by both countries “make Germany a strategic partner and ally of Mexico at the global level”.
Germany is Mexico’s most important trading partner in Europe, with trade exceeding $17,2 billion in 2013, as well as one of the chief allies of the Latin American country in global cooperation.
Some 1,700 German companies have investments in Mexico, where they employ more than 120,000 people.
The German minister, who began a two-day visit to Mexico on Friday and was received by President Enrique Peña Nieto, is accompanied by an entourage of businessmen.
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More